IAIM
CYT

International Assets Investment Management’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

International Assets Investment Management’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,400
Closed -$23.8K – 1387
2022
Q4 		$23.8K Buy
+14,400
New +$23.1K ﹤0.01% 779

Other funds holding CYT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

International Assets Investment Management's CYT Position: Q1 2023 in Review

International Assets Investment Management sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q1 2023, closing a stake of 14,400 shares — an estimated $23.8K sold.

International Assets Investment Management first reported a position in CYT in Q4 2022 and held it in 1 quarter. The position peaked at $23.8K in Q4 2022. 32 funds tracked by Wall St. Rank hold CYT as of Q1 2023.

  • International Assets Investment Management reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • International Assets Investment Management sold 14,400 Cyteir Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $23.8K.
  • International Assets Investment Management first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • International Assets Investment Management's Cyteir Therapeutics, Inc. Common Stock position peaked at $23.8K in Q4 2022.
  • 32 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q1 2023.

Based on International Assets Investment Management's 13F filing for Q1 2023, filed 19 Apr 2023.